Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.

Also called NCT06498323

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06498323
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Thailand (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06498323. Randomized; single masking; primary purpose treatment. Start 2022-08-03 (actual); primary completion 2025-08-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT
Condition
Intravenous
Condition
Thrombosis
Condition
Acute Ischemic Stroke
Intervention (Drug)
tenecteplase
Lead sponsor
Mahidol University (class: other)

Record details

Record id
cardio:ct-nct06498323
Content hash
c08869acf2d03e93ca47c2124babf29dcf83bdd608c4f86d17067438cbe0ad22